Identification of immune‐related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma

PURPOSE: Immunotherapy is changing head and neck squamous cell carcinoma (HNSCC) treatment pattern. According to the Chinese Society of Clinical Oncology (CSCO) guidelines, immunotherapy has been deemed as first‐line recommendation for recurrent/metastatic HNSCC, marking that advanced HNSCC has offi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qun, Shen, Zhisen, Shen, Yi, Deng, Hongxia, Shen, Yiming, Wang, Jianing, Zhan, Guowen, Zhou, Chongchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169191/
https://www.ncbi.nlm.nih.gov/pubmed/35561269
http://dx.doi.org/10.1002/jcla.24484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169191/
https://www.ncbi.nlm.nih.gov/pubmed/35561269
http://dx.doi.org/10.1002/jcla.24484

Ejemplares similares